https://lovastatininhibitor.co....m/amazingly-orientat
The presentation stage at the time of diagnosis was demonstrably higher in the COVID-era group compared to the pre-COVID group, achieving statistical significance (P = .0027). During the COVID-19 era, we observed a substantial increase in stage 3 or greater disease presentation. This contrasts with the pre-pandemic rate, which was 779%, whereas the COVID-19 rate was 123% (P = .016). Our analysis of breast cancer data before and during the COVID-19 pandemic ind
Like
Comment
Share
